drugset / Trial / NCT06347250

A Nerve Block Therapy for Bulbar Palsy Pharyngeal Dysphagia

NCT06347250

Completed 122 enrolled Babujinaya Cela
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This was a multicenter randomized controlled study. 66 post-stroke patients with pharyngeal dysphagia were randomly allocated to the observation group or the control group. Both groups were provided with comprehensive rehabilitation including routine rehabilitation and swallowing function training. Besides, the observation group additionally underwent the stellate ganglion block (SGB). At admission and after 20-day treatment,Yale Pharyngeal Residue Severity Rating Scale, video fluoroscopic swallowing study (VFSS), Functional Oral Intake Scale, and Rosenbek penetration-aspiration scale (PAS) were used to assess swallowing function.

Timeline

Start
2022-01-01
Primary completion
2023-05-02
Completion
2023-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1.5 ml Other
Subject Vitamin B12 Other / unclassified 500 ug Other

Indications